Literature DB >> 7903735

High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis.

C J Taylor, J A Dodge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7903735

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

Authors:  H P Haber; N Benda; G Fitzke; A Lang; M Langenberg; J Riethmüller; M Stern
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Oral ulceration and bleeding associated with pancreatic enzyme supplementation in a German shepherd with pancreatic acinar atrophy.

Authors:  Elisabeth Snead
Journal:  Can Vet J       Date:  2006-06       Impact factor: 1.008

3.  In Vitro Comparison of Physical Parameters, Enzyme Activity, Acid Resistance, and pH Dissolution Characteristics of Enteric-Coated Pancreatic Enzyme Preparations: Implications for Clinical Variability and Pharmacy Substitution.

Authors:  Robert J Kuhn; Sabine Eyting; Friederike Henniges; Andreas Potthoff
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

Review 4.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 5.  Adverse drug events related to dosage forms and delivery systems.

Authors:  I F Uchegbu; A T Florence
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

6.  Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis.

Authors:  D S Ablin; M Ziegler
Journal:  Pediatr Radiol       Date:  1995
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.